Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, Florida.
Curr Protoc. 2021 Jul;1(7):e189. doi: 10.1002/cpz1.189.
Cardiovascular pharmacogenomics is the study and identification of genomic markers that are associated with variability in cardiovascular drug response, cardiovascular drug-related outcomes, or cardiovascular drug-related adverse events. This overview presents an introduction and historical background to cardiovascular pharmacogenomics, and a protocol for designing a cardiovascular pharmacogenomics study. Important considerations are also included for constructing a cardiovascular pharmacogenomics phenotype, designing the replication or validation strategy, common statistical approaches, and how to put the results in context with the cardiovascular drug or cardiovascular disease under investigation. © 2021 Wiley Periodicals LLC. Basic Protocol: Designing a cardiovascular pharmacogenomics study.
心血管药物基因组学是研究和鉴定与心血管药物反应、心血管药物相关结局或心血管药物相关不良事件的变异性相关的基因组标记物。本综述介绍了心血管药物基因组学的介绍和历史背景，以及设计心血管药物基因组学研究的方案。还包括构建心血管药物基因组学表型、设计复制或验证策略、常见的统计方法以及如何将结果与正在研究的心血管药物或心血管疾病联系起来的重要考虑因素。© 2021 Wiley Periodicals LLC. 基本方案：设计心血管药物基因组学研究。
